BRD2 and hepatocellular carcinoma: Analysis of gene expression profiles of NAT in HCV-dominant HCC cohorts has demonstrated that peritumoral gene expression characteristics can reliably predict long-term survival and late recurrence (>2 years), surpassing the predictive ability of tumor tissue 20.